Warburg Research Analysts Give Aurubis (NDA) a €90.00 Price Target
Aurubis (ETR:NDA) has been assigned a €90.00 ($107.14) price target by research analysts at Warburg Research in a report issued on Monday. The brokerage currently has a “buy” rating on the stock. Warburg Research’s price objective points to a potential upside of 26.44% from the company’s current price.
A number of other equities research analysts have also weighed in on the company. Nord/LB set a €83.00 ($98.81) price objective on Aurubis and gave the company a “buy” rating in a report on Friday. Kepler Capital Markets set a €90.00 ($107.14) price objective on Aurubis and gave the company a “buy” rating in a report on Friday. Independent Research set a €77.00 ($91.67) price objective on Aurubis and gave the company a “neutral” rating in a report on Thursday. Hauck & Aufhaeuser set a €88.00 ($104.76) price objective on Aurubis and gave the company a “buy” rating in a report on Thursday. Finally, Baader Bank set a €74.00 ($88.10) price objective on Aurubis and gave the company a “neutral” rating in a report on Wednesday, December 13th. Six analysts have rated the stock with a sell rating, six have given a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of €72.21 ($85.97).
Shares of Aurubis (ETR NDA) opened at €71.18 ($84.74) on Monday. Aurubis has a twelve month low of €50.58 ($60.21) and a twelve month high of €79.29 ($94.39).
Aurubis AG engages in the copper concentrate processing, metal recycling, and copper product fabrication activities in Europe, Asia, the United States, and internationally. It operates in two segments, Primary Copper and Copper Products. The company procures and processes copper concentrates; produces and markets exchange-traded copper cathodes; and produces and markets sulfuric acid, iron silicate, precious metals, and specialty products.
Receive News & Ratings for Aurubis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurubis and related companies with MarketBeat.com's FREE daily email newsletter.